Literature DB >> 50251

Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.

K Okuda, K Kotoda, H Obata, N Hayashi, T Hisamitsu.   

Abstract

Five cases of hepatocellular carcinoma in whom diagnosis was made when the tumor was relatively small, are described. In 2 cases, serum alpha-fetoprotein (AFP) strted to rise sharply, which enabled early detection and surgical removal of the tumor. Serum AFP was below 100 ng per ml, but above the upper normal limit by radioimmunoassay, and was unfluctuating for a considerable period of time before it began to rise in 2 cases. It was negative throughout in 1 case, who lived more than 4 years after the tumor had reached a detectable size. In 4 of 5 cases, the tumor seemed to have evolved during a stage of chronic hepatitis or its transition to cirrhosis. In 1 case with chronic schistosomiasis and advanced mixed macro- and micronodular cirrhosis, a 1.5-cm tumor was detected by celiac angiography. These observations on time relationship of oncogenesis may be generalized to modify the cirrhotic liver. Necessity is emphasized for the early detection of this type of carcinoma to monitor serum AFP in chronic hepatitis patients, particularly in those with unfluctuating, mildly abnormal levels of AFP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50251

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.

Authors:  A Nakao; A Virji; Y Iwaki; B Carr; S Iwatsuki; E Starzl
Journal:  Hepatogastroenterology       Date:  1991-10

Review 2.  Primary liver cancer and its relationship to chronic infection with the hepatitis B virus.

Authors:  S J Hadziyannis
Journal:  Springer Semin Immunopathol       Date:  1981-04

3.  A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP.

Authors:  Shiro Murashima; Masatoshi Tanaka; Makoto Haramaki; Shigeru Yutani; Yutaka Nakashima; Kazunori Harada; Tatsuya Ide; Ryukichi Kumashiro; Michio Sata
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

4.  Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis.

Authors:  David F Stein; Malay Myaing
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

5.  Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.

Authors:  P J Johnson; B Portmann; R Williams
Journal:  Br Med J       Date:  1978-09-02

6.  Small liver cancer.

Authors:  T Kanematsu; K Takenaka; T Matsumata; T Furuta; K Sugimachi; K Inokuchi
Journal:  Jpn J Surg       Date:  1983-01

7.  The effect of estriol on the production of alpha-fetoprotein by the liver in adult mice.

Authors:  M Kotani; H Fujii; K Terao; T Hayama; H Taga; H Hirai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

8.  MicroRNA profile of hepatic epithelioid hemangioendothelioma: A case report.

Authors:  Asahiro Morishita; Hisakazu Iwama; Hirohito Yoneyama; Teppei Sakamoto; Koji Fujita; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Shintaro Fujihara; Noriko Nishiyama; Hideki Kobara; Hirohito Mori; Naoki Yamamoto; Keiichi Okano; Yasuyuki Suzuki; Emi Ibuki; Reiji Haba; Takashi Himoto; Tsutomu Masaki
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.